Sino Medical Sciences Technology Inc.

Shanghai Stock Exchange 688108.SS

Sino Medical Sciences Technology Inc. Net Income for the year ending December 31, 2023: USD -5.58 M

Sino Medical Sciences Technology Inc. Net Income is USD -5.58 M for the year ending December 31, 2023, a 77.77% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Sino Medical Sciences Technology Inc. Net Income for the year ending December 31, 2022 was USD -25.11 M, a -21.54% change year over year.
Sino Medical Sciences Technology Inc. Net Income for the year ending December 31, 2021 was USD -20.66 M, a -699.65% change year over year.
Sino Medical Sciences Technology Inc. Net Income for the year ending December 31, 2020 was USD 3.45 M, a -73.35% change year over year.
Sino Medical Sciences Technology Inc. Net Income for the year ending December 31, 2019 was USD 12.93 M, a -0.30% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shanghai Stock Exchange: 688108.SS

Sino Medical Sciences Technology Inc.

CEO	Mr. Jianhua Sun
IPO Date	Oct. 30, 2019
Location	China
Headquarters	TEDA Biopharm Res, Building B
Employees	652
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Clinical Trials Pharmaceuticals

Description

Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional devices in China. Its products include drug-eluting stents, balloon catheters, coronary stents, and transcatheter mitral valve replacement devices. Sino Medical Sciences Technology Inc. has a clinical collaboration agreement with The National University of Ireland Galway. The company was founded in 2007 and is headquartered in Tianjin, China.

Key trends

Past 5 years